These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 23374361)

  • 1. Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma.
    Tohme S; Geller DA; Cardinal JS; Chen HW; Packiam V; Reddy S; Steel J; Marsh JW; Tsung A
    HPB (Oxford); 2013 Mar; 15(3):210-7. PubMed ID: 23374361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.
    Wong KM; Yeh ML; Chuang SC; Wang LY; Lin ZY; Chen SC; Tsai JF; Wang SN; Kuo KK; Dai CY; Yu ML; Lee KT; Chuang WL
    Indian J Gastroenterol; 2013 Jul; 32(4):253-7. PubMed ID: 22932964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
    Hu L; Lin J; Wang A; Shi X; Qiao Y
    World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
    Dong W; Zhang T; Wang ZG; Liu H
    World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
    Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Gavriilidis P; Askari A; Azoulay D
    HPB (Oxford); 2017 Jan; 19(1):3-9. PubMed ID: 28341429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma.
    Parisi A; Desiderio J; Trastulli S; Castellani E; Pasquale R; Cirocchi R; Boselli C; Noya G
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):270-7. PubMed ID: 23742772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma.
    Sakoda M; Ueno S; Iino S; Minami K; Ando K; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S
    World J Surg; 2013 Mar; 37(3):597-601. PubMed ID: 23192169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.
    Yamashita YI; Imai K; Kaida T; Yamao T; Tsukamoto M; Nakagawa S; Okabe H; Chikamoto A; Ishiko T; Yoshizumi T; Ikeda T; Maehara Y; Baba H
    Surg Endosc; 2019 Jan; 33(1):46-51. PubMed ID: 29872945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.
    Ng KKC; Chok KSH; Chan ACY; Cheung TT; Wong TCL; Fung JYY; Yuen J; Poon RTP; Fan ST; Lo CM
    Br J Surg; 2017 Dec; 104(13):1775-1784. PubMed ID: 29091283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
    Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
    J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.